期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基因敲除与基因突变动物模型在药物跨膜转运研究中的应用 被引量：3

Application of Gene Knockout and Gene Defect Models in the Study of Drug Membrane Transport
下载PDF
导出
摘要 ABC类载体蛋白(ATP binding cassette)家族中的药物转运蛋白影响许多药物的药代动力学过程。P-糖蛋白(P-gp),多药耐药相关蛋白(MRP),乳腺癌耐药蛋白(BCRP)同属于ABC类载体蛋白。转运蛋白基因缺失动物模型是目前对膜转运蛋白作用机制研究的重要手段。各种转运蛋白缺失的大鼠和小鼠模型是研究其所对应缺失的转运蛋白的生理作用以及研究各种药物在组织中的聚集和毒性情况的一种很好的模型。本文综述了转运蛋白基因缺失动物模型在转运蛋白作用机制、转运行为和寻找新的转运蛋白抑制剂方面的应用。 Active drug transporters of the ATP binding cassette （ABC）-containing family of proteins have a major impact on the pharmacokinetics of most drugs in use today. P-glycoprotein （P-gp）, multidrug resistance-associated protein（MRP）, and breast cancer resistance protein （BCRP） are ABC-superfamily of membrane transport proteins （transporters）. The transporter gene knockout mouse/rat models have been proven to be a useful tool in the study of the role of transporters in tissue accumulation and toxicity of various organic chemicals. This paper reviewed the applications of the transporter gene knockout mouse/rat models on transporters＇mechanism, aiming to search new applications of the transporter inhibitor.
作者 何卉 陈西敬 王广基
机构地区 中国药科大学药物代谢与动力学研究中心
出处 《中国药科大学学报》 CAS CSCD 北大核心 2005年第6期483-487,共5页 Journal of China Pharmaceutical University
关键词 药物转运蛋白 基因敲除 药代动力学 Drug transporters Gene knockout Pharmacokinetics
分类号 R96 [医药卫生—药理学]
  • 相关文献

参考文献23

  • 1赵小平,柳晓泉,王广基.基因敲除模型与药物作用新靶点的发现[J].中国药科大学学报,2004,35(1):1-6. 被引量：5
  • 2Schinkel AH,Smit JJM,Van Tellingen O,et al.Disruption of the mouse mdr 1 a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs[J].Cell,1994,77(4) :491 - 502.
  • 3Sparreboom A,Van Asperen J,Mayer U,et al.Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine[J].Proc Natl Acad Sci USA,1997,94(5) :2 031 - 2 035.
  • 4Stephens RH,Tanianis-hughes J,Higgs NB,et al.Region-dependent modulation of intestinal permeability by drug efflux transporters:in vitro studies in mdr1a (-/-) mouse intestine[J].J Pharmacol Exp Ther,2002,303(3):1 095 - 1 101.
  • 5Song SH,Suzuki H,Kawai R,et al.Effect of PSC 833,a P-glycoprotein modulator,on the disposition of vincristine and digoxin in rats[J].Drug Metab Dispos,1999,27(6) :689 - 694.
  • 6Press RR,Buckle T,Beijnen JH,et al.The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice[J].Cancer Chemother Pharmacol,2005,15:1 - 7.
  • 7Uhr M,Grauer MT.Abcblab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice[J].Psychiatric Res ,2003,37(3):179 - 185.
  • 8Xie Y,Liu J,Liu Y,et al.Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b (-/-) double knockout mice[J].Mol Cell Biochem ,2004,255 (1 - 2):11-18.
  • 9Elamiri A,Perwaiz S,Tuchweber B,et al.Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice [J].Pharmacol Res,2003,48(5):467 - 472.
  • 10Cole SP,Bhardwaj G,Gerlach JH,et al.Overexpression of a novel transporter gene in a multidrug-resistant human lung cancer cell line[J].Science,1992,258(5 088):1 650 - 1 654.

二级参考文献31

  • 1[1]Hopkins AL,Groom CR.The druggable genome [ J ].Nature RevDrug Discov,2002,1:723-730.
  • 2[2]Scappini B.Onida F,Kantarjian HM,et al.In vitro effect of STI571-containing drug combinations on the growth of philadelphiapositive chronic myelogenous leukemia cells[ J ].Cancer,2002,94:2653-2662.
  • 3[3]Scarff KL,Judd LM,Toh BH,et al.Gastric H+ ,K+ -adenosine triphosphatase β subunit is required for normal function,development,and membrane structure of mouse parietal cells [ J ] .Gastroenterology,1999,117:605-668.
  • 4[4]Lieschke GJ,Grail D,Hodgson G,et al.Mice lacking granulocyte colonystimulating factor have chronic neutropenia,granulocyte and macrophage progenitor cell deficiency,and impaired neutrophil mobilization[J].Blood ,2000,84:1737-1746.
  • 5[5]Langenbach R,Morham SG,Tiano HF,et al.Prostaaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration[ J ].Cell,1995,83:483-492.
  • 6[6]Mroteau O,Morham SG,Sellon R,et al.Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2 [ J].J Clin Invest,2000,105:469-478.
  • 7[7]Ballou LR,Botting RM,Goorha S,et al.Nociception in cyclooxygenase isozyme-deficient mice[J].Proc Natl Acad Sci USA,2000,97:10272-10276.
  • 8[8]Chulada PC,Thompson MB,Mahler JF,et al.Genetic disruption of Ptgs-1,as well as Ptgs-2,reduces intestinal tumorigenesis in mice[ J ] .Cancer Res,2000,60(17),4705-4708.
  • 9[9]Tiano HF,Loftin CD,Akunda J,et al.Deficiency of either cyclooxygenase(COX)-1 or(COX)-2 alters epidermal diffrentiation and reduces mouse skin tumorigenesis [ J ] .Cancer Res,2002,62(12):3395-401.
  • 10[10]Morham SG,Langenbach R,Loftin CD,et al.Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse [ J ].Cell,1995,83:473-482.

共引文献4

同被引文献40

引证文献3

二级引证文献14

中国药科大学学报
2005年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部